Gillingwater Thomas H, Ingham Cali A, Parry Katherine E, Wright Ann K, Haley Jane E, Wishart Thomas M, Arbuthnott Gordon W, Ribchester Richard R
Centre for Neuroscience Research, University of Edinburgh, Edinburgh, UK.
Brain. 2006 Jun;129(Pt 6):1546-56. doi: 10.1093/brain/awl101.
Therapies that might delay degeneration of synapses offer an appealing strategy for treatment of neurodegenerative diseases, including Alzheimer's disease and related dementias, prion diseases, schizophrenia and amyotrophic lateral sclerosis. Analysis of mouse mutants provides one possible avenue towards identifying relevant mechanisms. Here, we used quantitative and serial section electron microscopy to find out whether the onset and time course of pre-synaptic nerve terminal degeneration is delayed in the striatum of Wallerian degeneration slow (Wld(s)) mutant mice. Synaptic degeneration was observed within 48 h of cortical ablation in wild-type mice but was delayed by approximately 1 week in Wld(s) mice. However, the morphological characteristics of degenerating nerve terminals in wild-type and Wld(s) mice were indistinguishable, in contrast to the differences reported previously in studies of the PNS. Surprisingly, the delayed onset of synaptic degeneration was accompanied by an increased incidence of complex synaptic morphologies on post-synaptic spines in the denervated Wld(S) striatum indicating an enhanced plastic response at both injured and uninjured synapses. The data suggest that targeting Wallerian-like mechanisms of synaptic degeneration could lead to the development of new therapies for the treatment of CNS disorders where synapse loss is a primary feature.
可能延缓突触退化的疗法为治疗神经退行性疾病提供了一种有吸引力的策略,这些疾病包括阿尔茨海默病及相关痴呆症、朊病毒病、精神分裂症和肌萎缩侧索硬化症。对小鼠突变体的分析为确定相关机制提供了一条可能的途径。在这里,我们使用定量和连续切片电子显微镜来研究在沃勒变性慢(Wld(s))突变小鼠的纹状体中,突触前神经末梢退化的起始和时间进程是否延迟。在野生型小鼠中,皮质切除后48小时内观察到突触退化,但在Wld(s)小鼠中延迟了约1周。然而,野生型和Wld(s)小鼠中退化神经末梢的形态特征无法区分,这与之前在周围神经系统研究中报道的差异形成对比。令人惊讶的是,突触退化的延迟起始伴随着去神经支配的Wld(S)纹状体中突触后棘上复杂突触形态发生率的增加,表明在受损和未受损突触处都有增强的可塑性反应。数据表明,针对类似沃勒变性的突触退化机制可能会导致开发出治疗中枢神经系统疾病的新疗法,在这些疾病中突触丧失是主要特征。